An update on the pharmacotherapeutic options for complex regional pain syndrome

References

• Nicholas M, Vlaeyen JWS, Rief W, et al. IASP taskforce for the classification of chronic pain. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019 Jan;160(1):28–37. doi: 10.1097/j.pain.0000000000001390
   PubMed Web of Science ®Google Scholar
• Harden NR, Bruehl S, RSGM P, et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for complex regional pain syndrome. Pain. 2010 Aug;150(2):268–274. doi: 10.1016/j.pain.2010.04.030
   PubMed Web of Science ®Google Scholar
• Iolascon G, Tarantino U. Rare diseases in orthopedics: algodystrophy and aseptic osteonecrosis. Clin Cases Miner Bone Metab. 2015 Jan;12(Suppl 1):2–3.
   PubMedGoogle Scholar
• De Sire A, Paoletta M, Moretti A, et al. Complex regional pain syndrome: facts on causes, diagnosis and therapy. Clin Cases Mineral Bone Metab. 2018 May 1;15(2):166–172.
   Google Scholar
• Moretti A, Gimigliano F, Paoletta M, et al. Complex regional pain syndrome type I following non-orthopedic surgery: case report and narrative review. Diagnostics (Basel). 2021 Sep 1;11(9):1596. doi: 10.3390/diagnostics11091596
   PubMedGoogle Scholar
• Moretti A, Palomba A, Paoletta M, et al. Complex Regional Pain Syndrome in Athletes: Scoping Review. Medicina (Kaunas). 2021 Nov 17;57(11):1262. PMID: 34833480; PMCID: PMC8623027. doi: 10.3390/medicina57111262
   PubMed Web of Science ®Google Scholar
• Corradini C, Bosizio C, Moretti A. Algodystrophy (CRPS) in minor orthopedic surgery. Clin Cases Miner Bone Metab. 2015 Jan;12(Suppl 1):21–25. doi: 10.11138/ccmbm/2015.12.3s.021
   PubMedGoogle Scholar
• Goebel A, Birklein F, Brunner F, et al. The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria. Pain. 2021 Sep 1;162(9):2346–2348. doi: 10.1097/j.pain.0000000000002245
   PubMed Web of Science ®Google Scholar
• Veldman PH, Reynen HM, Arntz IE, et al. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993 Oct 23;342(8878):1012–1016. doi: 10.1016/0140-6736(93)92877-v
   PubMed Web of Science ®Google Scholar
• Iolascon G, de Sire A. Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues. Clin Cases Miner Bone Metab. 2015 Jan;12(Suppl 1):4–10. doi: 10.11138/ccmbm/2015.12.3s.004
   PubMedGoogle Scholar
• Ott S, Maihöfner C. Signs and symptoms in 1,043 patients with complex regional pain syndrome. J Pain. 2018 Jun;19(6):599–611. doi: 10.1016/j.jpain.2018.01.004
   PubMed Web of Science ®Google Scholar
• Beerthuizen A, Stronks DL, Van’t Spijker A, et al. Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): prospective study on 596 patients with a fracture. Pain. 2012 Jun;153(6):1187–1192. doi: 10.1016/j.pain.2012.01.026
   PubMed Web of Science ®Google Scholar
• Murphy KR, Han JL, Yang S, et al. Prevalence of specific types of pain diagnoses in a sample of United States adults. Pain Physician. 2017 Feb;20(2):E257–E268. PMID: 28158163. doi: 10.36076/ppj.2017.E268
   PubMed Web of Science ®Google Scholar
• Elsamadicy AA, Yang S, Sergesketter AR, et al. Prevalence and cost analysis of complex regional pain syndrome (CRPS): a role for neuromodulation. Neuromodulation. 2018, Jul;21(5):423–430.
   PubMed Web of Science ®Google Scholar
• Resmini G, Ratti C, Canton G, et al. Treatment of complex regional pain syndrome. Clin Cases Miner Bone Metab. 2015 Jan;12(Suppl 1):26–30. doi: 10.11138/ccmbm/2015.12.3s.026
   PubMedGoogle Scholar
• Iolascon G, Moretti A. Pharmacotherapeutic options for complex regional pain syndrome. Expert Opin Pharmacother. 2019 Aug;20(11):1377–1386. doi: 10.1080/14656566.2019.1612367
   PubMed Web of Science ®Google Scholar
• Bruehl S. Complex regional pain syndrome. BMJ. 2015 Jul 29;351:h2730. PMID: 26224572. doi: 10.1136/bmj.h2730
   PubMedGoogle Scholar
• Marinus J, Moseley GL, Birklein F, et al. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol. 2011 Jul;10(7):637–48. doi: 10.1016/S1474-4422(11)70106-5
   PubMed Web of Science ®Google Scholar
• Wehmeyer C, Pap T, Buckley CD, et al. The role of stromal cells in inflammatory bone loss. Clin Exp Immunol. 2017, Jul;189(1):1–11.
   PubMed Web of Science ®Google Scholar
• Ritz BW, Alexander GM, Nogusa S, et al. Elevated blood levels of inflammatory monocytes (CD14+ CD16+) in patients with complex regional pain syndrome. Clin Exp Immunol. 2011, Apr;164(1):108–117.
   PubMed Web of Science ®Google Scholar
• Pohóczky K, Kun J, Szentes N, et al. Discovery of novel targets in a complex regional pain syndrome mouse model by transcriptomics: TNF and JAK-STAT pathways. Pharmacol Res. 2022 Aug;182: 106347. doi: 10.1016/j.phrs.2022.106347
   PubMed Web of Science ®Google Scholar
• König S, Bayer M, Dimova V, et al. The serum protease network-one key to understand complex regional pain syndrome pathophysiology. Pain. 2019 Jun;160(6):1402–1409. doi: 10.1097/j.pain.0000000000001503
   PubMed Web of Science ®Google Scholar
• Birklein F, Schmelz M, Schifter S, et al. The important role of neuropeptides in complex regional pain syndrome. Neurology. 2001 Dec 26;57(12):2179–2184. doi: 10.1212/wnl.57.12.2179
   PubMed Web of Science ®Google Scholar
• Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis. 2001 Feb;8(1):1–10. doi: 10.1006/nbdi.2000.0360
   PubMed Web of Science ®Google Scholar
• Freund W, Wunderlich AP, Stuber G, et al. The role of periaqueductal gray and cingulate cortex during suppression of pain in complex regional pain syndrome. Clin J Pain. 2011 Nov;27(9):796–804. doi: 10.1097/AJP.0b013e31821d9063
   PubMed Web of Science ®Google Scholar
• Cheng JK, Ji RR. Intracellular signaling in primary sensory neurons and persistent pain. Neurochem Res. 2008, Oct;33(10):1970–1978. doi: 10.1007/s11064-008-9711-z
   PubMed Web of Science ®Google Scholar
• Wang H, Kohno T, Amaya F, et al. Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission. J Neurosci. 2005 Aug 31;25(35):7986–7992. doi: 10.1523/JNEUROSCI.2393-05.2005
   PubMed Web of Science ®Google Scholar
• Nijs J, George SZ, Clauw DJ, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3(5):e383–e392. doi: 10.1016/S2665-9913(21)00032-1
   PubMedGoogle Scholar
• Harte SE, Harris RE, Clauw DJ. The neurobiology of central sensitization. J Appl Behav Res. 2018;23(2):e12137. doi: 10.1111/jabr.12137
   Web of Science ®Google Scholar
• Schlereth T, Birklein F. The sympathetic nervous system and pain. NeuroMol Med. 2008;10(3):141–147. Epub 2007 Nov 8. PMID: 17990126. doi: 10.1007/s12017-007-8018-6
   PubMed Web of Science ®Google Scholar
• Sato J, Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science. 1991 Mar 29;251(5001):1608–1610. PMID: 2011742. doi: 10.1126/science.2011742
   PubMed Web of Science ®Google Scholar
• Jeong CY, Choi JI, Yoon MH. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol. 2004 Oct 19. 502(3): 205–211. PMID: 15476746. doi: 10.1016/j.ejphar.2004.08.048
   PubMed Web of Science ®Google Scholar
• Dogrul A, Ossipov MH, Porreca F. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res. 2009 Jul 14. 1280:52–59. Epub 2009 May 8. PMID: 19427839. doi: 10.1016/j.brainres.2009.05.001
   PubMed Web of Science ®Google Scholar
• Park JH, Lee CH, Ham HD, et al. Analgesic effects of a 5-HT3 receptor antagonist in an animal model of complex regional pain syndrome. Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7051–7057. PMID: 34859869. doi: 10.26355/eurrev_202111_27256
   PubMed Web of Science ®Google Scholar
• Helyes Z, Tékus V, Szentes N, et al. Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms. Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13067–13076. Epub 2019 Jun 10. Erratum in: Proc Natl Acad Sci U S A. 2019 Jul 8;: PMID: 31182576; PMCID: PMC6600930. doi: 10.1073/pnas.1820168116
   PubMed Web of Science ®Google Scholar
• Goebel A, Barker C, Birklein F, et al. Standards for the diagnosis and management of complex regional pain syndrome: results of a European pain federation task force. Eur J Pain. 2019 Apr;23(4):641–651. doi: 10.1002/ejp.1362
   PubMed Web of Science ®Google Scholar
• Goebel A, Barker CH, Turner-Stokes L, et al. Complex regional pain syndrome in adults: uK guidelines for diagnosis, referral and management in primary and secondary care. London: RCP; 2018.
   Google Scholar
• Grieve S, Jones L, Walsh N, et al. What outcome measures are commonly used for complex regional pain syndrome clinical trials? A systematic review of the literature. Eur J Pain. 2016 Mar;20(3):331–340. Epub 2015 Jun 15. PMID: 26075938. doi: 10.1002/ejp.733
   PubMed Web of Science ®Google Scholar
• Llewellyn A, McCabe CS, Hibberd Y, et al. Are you better? A multi-centre study of patient-defined recovery from complex regional pain syndrome. European Journal Of Pain. 2018 Mar;22(3):551–564. Epub 2017 Dec 1. PMID: 29194871. doi: 10.1002/ejp.1138
   PubMed Web of Science ®Google Scholar
• Birklein F, Ajit SK, Goebel A, et al. Complex regional pain syndrome - phenotypic characteristics and potential biomarkers. Nat Rev Neurol. 2018 May;14(5):272–284. Epub 2018 Mar 16. PMID: 29545626; PMCID: PMC6534418. doi: 10.1038/nrneurol.2018.20
   PubMed Web of Science ®Google Scholar
• Shenoda BB, Alexander GM, Ajit SK. Hsa-miR-34a mediated repression of corticotrophin releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with complex regional pain syndrome. J Transl Med. 2016 Mar 3;14:64. doi: 10.1186/s12967-016-0820-1
   PubMed Web of Science ®Google Scholar
• Cohen SP, Khunsriraksakul C, Yoo Y, et al. Sympathetic blocks as a predictor for response to ketamine infusion in patients with complex regional pain syndrome: a multicenter study. Pain Med. 2023 Mar 1;24(3): 316–324. PMID: 36269190. doi: 10.1093/pm/pnac153
   PubMed Web of Science ®Google Scholar
• Varenna M, Manara M, Rovelli F, et al. Predictors of responsiveness to bisphosphonate treatment in patients with complex regional pain syndrome type I: a retrospective chart analysis. Pain Med. 2017 Jun 1;18(6):1131–1138. PMID: 27651505. doi: 10.1093/pm/pnw207
   PubMed Web of Science ®Google Scholar
• Tsagareli MG, Nozadze I, Tsiklauri N, et al. Non-steroidal anti-inflammatory drugs attenuate agonist-evoked activation of transient receptor potential channels. Biomed Pharmacother. 2018 Jan;97:745–751. Epub 2017 Nov 6. PMID: 29102918: doi: 10.1016/j.biopha.2017.10.131
   PubMed Web of Science ®Google Scholar
• Eckmann MS, Ramamurthy S, Griffin JG. Intravenous regional ketorolac and lidocaine in the treatment of complex regional pain syndrome of the lower extremity: a randomized, double-blinded, crossover study. Clin J Pain. 2011, Mar;27(3):203–206. doi: 10.1097/AJP.0b013e3181fd5150
   PubMed Web of Science ®Google Scholar
• Breuer AJ, Mainka T, Hansel N, et al. Short-term treatment with parecoxib for complex regional pain syndrome: a randomized, placebo-controlled double-blind trial. Pain Physician. 2014 Mar;17(2):127–137. PMID: 24658473. doi: 10.36076/ppj.2014/17/127
   PubMed Web of Science ®Google Scholar
• Maihöfner C, Handwerker HO, Neundörfer B, et al. Mechanical hyperalgesia in complex regional pain syndrome: a role for TNF-alpha? Neurology. 2005 Jul 26. 65(2): 311–313. PMID: 16043808. doi: 10.1212/01.wnl.0000168866.62086.8f
   PubMed Web of Science ®Google Scholar
• Kalita J, Vajpayee A, Misra UK. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. QJM. 2006 Feb;99(2):89–95. Epub 2006 Jan 20. PMID: 16428335. doi: 10.1093/qjmed/hcl004
   PubMed Web of Science ®Google Scholar
• Atalay NS, Ercidogan O, Akkaya N, et al. Prednisolone in complex regional pain syndrome. Pain Physician. 2014 Mar;17(2):179–185. PMID: 24658479. doi: 10.36076/ppj.2014/17/179
   PubMed Web of Science ®Google Scholar
• Kalita J, Misra U, Kumar A, et al. Long-term prednisolone in post-stroke complex regional pain syndrome. Pain Physician. 2016 Nov;19(8):565–574. PMID: 27906935. doi: 10.36076/ppj/2016.19.565
   PubMed Web of Science ®Google Scholar
• Barbalinardo S, Loer SA, Goebel A, et al. The treatment of longstanding complex regional pain syndrome with oral steroids. Pain Med. 2016 Feb;17(2):337–343. doi: 10.1093/pm/pnv002
   PubMed Web of Science ®Google Scholar
• Eun Young H, Hyeyun K, Sang Hee I. Pamidronate effect compared with a steroid on complex regional pain syndrome type I: pilot randomised trial. Neth J Med. 2016 Jan;74(1):30–5.
   PubMed Web of Science ®Google Scholar
• Kalita J, Pandey PC, Shukla R, et al. Prednisolone 20 mg vs 40 mg in complex regional pain syndrome type I: a randomized controlled trial. J Clin Neurosci. 2023 Jul;113:108–113. Epub 2023 May 29. PMID: 37257216: doi: 10.1016/j.jocn.2023.05.017
   PubMed Web of Science ®Google Scholar
• Scholz J, Finnerup NB, Attal N, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019 Jan;160(1):53–59. doi: 10.1097/j.pain.0000000000001365
   PubMed Web of Science ®Google Scholar
• Kwak SG, Choo YJ, Chang MC. Effectiveness of prednisolone in complex regional pain syndrome treatment: a systematic narrative review. Pain Pract. 2022 Mar;22(3):381–390. Epub 2021 Nov 25. PMID: 34779145. doi: 10.1111/papr.13090
   PubMed Web of Science ®Google Scholar
• van den Berg C, de Bree PN, FJPM H, et al. Glucocorticoid treatment in patients with complex regional pain syndrome: a systematic review. Eur J Pain. 2022 Nov;26(10):2009–2035. Epub 2022 Sep 2. PMID: 35983980; PMCID: PMC9826269. doi: 10.1002/ejp.2025
   PubMed Web of Science ®Google Scholar
• Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010 Jan 19. 152(2): 85–92. PMID: 20083827; PMCID: PMC3000551. doi: 10.7326/0003-4819-152-2-201001190-00006
   PubMed Web of Science ®Google Scholar
• Brush DE. Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia. J Med Toxicol. 2012 Dec;8(4):387–392. PMID: 22983894; PMCID: PMC3550256. doi: 10.1007/s13181-012-0260-0
   PubMedGoogle Scholar
• Gustin SM, Schwarz A, Birbaumer N, et al. NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. Pain. 2010 Oct;151(1):69–76. Epub 2010 Jul 13. PMID: 20630656. doi: 10.1016/j.pain.2010.06.022
   PubMed Web of Science ®Google Scholar
• Goebel A. Morphine and memantine treatment of long-standing complex regional pain syndrome. Pain Med. 2012 Mar;13(3):357–358. doi: 10.1111/j.1526-4637.2011.01317.x
   PubMed Web of Science ®Google Scholar
• O’Connell NE, Wand BM, McAuley J, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD009416. Update in: Cochrane Database Syst Rev. 2023 Jun 12;6:CD009416. PMID: 23633371; PMCID: PMC6469537. doi: 10.1002/14651858.CD009416.pub2.
   PubMedGoogle Scholar
• Wertli MM, Kessels AG, Perez RS, et al. Rational pain management in complex regional pain syndrome 1 (CRPS 1)–a network meta-analysis. Pain Med. 2014 Sep;15(9):1575–1589. PMID: 25234478. doi: 10.1111/pme.12466
   PubMed Web of Science ®Google Scholar
• Benzon HT, Liu SS, Buvanendran A. Evolving definitions and pharmacologic management of complex regional pain syndrome. Anesth Analg. 2016 Mar;122(3):601–604. PMID: 26891387. doi: 10.1213/ANE.0000000000001157
   PubMed Web of Science ®Google Scholar
• In brief: cancer risk with salmon calcitonin. Med Lett Drugs Ther. 2013 Apr 15;55(1414):29. PMID: 23588101.
   Web of Science ®Google Scholar
• FDA. Questions and answers: changes to the indicated population for Miacalcin (calcitonin-salmon). [cited 2019 Feb 19]. Available from: https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm388641.htm
   Google Scholar
• Questions and answers on the review of calcitonin containing medicines outcome of a procedure under article 31 of directive 2001/83/EC. [cited 2019 Feb 19]. Available from: https://www.ema.europa.eu/en/medicines/human/referrals/calcitonin
   Google Scholar
• Perez RS, Kwakkel G, Zuurmond WW, et al. Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials. J Pain Symptom Manage. 2001 Jun;21(6):511–526. doi: 10.1016/s0885-3924(01)00282-2
   PubMed Web of Science ®Google Scholar
• Gobelet C, Waldburger M, Meier JL. The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain. 1992, Feb;48(2):171–175. doi: 10.1016/0304-3959(92)90055-G
   PubMed Web of Science ®Google Scholar
• Hamamci N, Dursun E, Ural C, et al. Calcitonin treatment in reflex sympathetic dystrophy: a preliminary study. Br J Clin Pract. 1996 Oct;50(7):373–375. PMID: 9015909. doi: 10.1111/j.1742-1241.1996.tb09579.x
   PubMedGoogle Scholar
• Sahin F, Yilmaz F, Kotevoglu N, et al. Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy. Clin Rheumatol. 2006 Mar;25(2):143–148. Epub 2005 Jun 25. PMID: 15980934. doi: 10.1007/s10067-005-1153-2
   PubMed Web of Science ®Google Scholar
• Gatti D, Rossini M, Adami S. Management of patients with complex regional pain syndrome type I. Osteoporos Int. 2016, Aug;27(8):2423–2431. doi: 10.1007/s00198-016-3531-9
   PubMed Web of Science ®Google Scholar
• Fassio A, Mantovani A, Gatti D, et al. Pharmacological treatment in adult patients with CRPS-I: a systematic review and meta-analysis of randomized controlled trials. Rheumatology (Oxford). 2022 Aug 30;61(9):3534–3546. PMID: 35104332. doi: 10.1093/rheumatology/keac060
   PubMed Web of Science ®Google Scholar
• Varenna M, Adami S, Sinigaglia L. Bisphosphonates in complex regional pain syndrome type I: how do they work? Clin Exp Rheumatol. 2014 Jul;32(4):451–454.
   PubMed Web of Science ®Google Scholar
• Maihöfner C, Seifert F, Markovic K. Complex regional pain syndromes: new pathophysiological concepts and therapies. Eur J Neurol. 2010 May;17(5):649–60. Epub 2010 Feb 18. PMID: 20180838. doi: 10.1111/j.1468-1331.2010.02947.x
   PubMed Web of Science ®Google Scholar
• Varenna M, Zucchi F, Ghiringhelli D, et al. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol. 2000 Jun;27(6):1477–1483. PMID: 10852274
   PubMed Web of Science ®Google Scholar
• Manicourt DH, Brasseur JP, Boutsen Y, et al. Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis Rheum. 2004 Nov;50(11):3690–3697. PMID: 15529370. doi: 10.1002/art.20591
   PubMed Web of Science ®Google Scholar
• Robinson JN, Sandom J, Chapman PT. Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med. 2004 Sep;5(3):276–280. PMID: 15367305. doi: 10.1111/j.1526-4637.2004.04038.x
   PubMed Web of Science ®Google Scholar
• Varenna M, Adami S, Rossini M, et al. Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. Rheumatology (Oxford). 2013 Mar;52(3):534–542. doi: 10.1093/rheumatology/kes312
   PubMed Web of Science ®Google Scholar
• Faggiani M, Piccato A, Baroni C, et al. Intravenous treatment with biphosphates in complex regional pain syndrome. Acta Biomed.2021 Sep 2;92(4):e2021190. doi: 10.23750/abm.v92i4.11194
   PubMedGoogle Scholar
• Varenna M, Braga V, Gatti D, et al. Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study. Ther Adv Musculoskelet Dis. 2021 Jun 11;13:1759720X211014020. doi: 10.1177/1759720X211014020
   PubMed Web of Science ®Google Scholar
• Varenna M, Gatti D, Zucchi F, et al. Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study. Ther Adv Musculoskelet Dis. 2022 Dec 19;14:1759720X221142274. doi: 10.1177/1759720X221142274
   PubMed Web of Science ®Google Scholar
• Walfish L, Sbrocchi AM, Rivera G, et al. Use of bisphosphonates in a retrospective case series of children and adolescents with complex regional pain syndrome. Paediatr Anaesth. 2021 Aug;31(8):871–877. Epub 2021 Jun 3. PMID: 33999470. doi: 10.1111/pan.14207
   PubMed Web of Science ®Google Scholar
• Chevreau M, Romand X, Gaudin P, et al. Bisphosphonates for treatment of complex regional pain syndrome type 1: a systematic literature review and meta-analysis of randomized controlled trials versus placebo. Joint Bone Spine. 2017 Jul;84(4):393–399. Epub 2017 Apr 11. PMID: 28408275. doi: 10.1016/j.jbspin.2017.03.009
   PubMed Web of Science ®Google Scholar
• Rossini M, Adami S, Viapiana O, et al. Long-term effects of amino-bisphosphonates on circulating γδ T cells. Calcif Tissue Int. 2012 Dec;91(6):395–399. Epub 2012 Oct 4. PMID: 23052225. doi: 10.1007/s00223-012-9647-9
   PubMed Web of Science ®Google Scholar
• Kolacz M, Kosson D, Puchalska-Kowalczyk E, et al. Analysis of antidepressant, Benzodiazepine Anxiolytic, and hypnotic use when treating depression, anxiety, and aggression in pain clinic patients treated for neuropathic pain. Life (Basel). 2022 Mar 16;12(3):433. doi: 10.3390/life12030433
   PubMed Web of Science ®Google Scholar
• Van de Vusse AC, Stomp-van den Berg SG, Kessels AH, et al. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1 [ISRCTN84121379]. BMC neurol. 2004 Sep 29;4:13.doi: 10.1186/1471-2377-4-13
   PubMed Web of Science ®Google Scholar
• Brown S, Johnston B, Amaria K, et al. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand J Pain. 2016 Oct;13: 156–163. doi: 10.1016/j.sjpain.2016.05.039
   PubMed Web of Science ®Google Scholar
• Fallico N, Padmanabhan R, Rahman S, et al. A randomised placebo-controlled clinical trial on the efficacy of local lidocaine injections and oral citalopram for the treatment of complex regional pain syndrome. J Plast Reconstr Aesthet Surg. 2022, Mar;75(3):970–979.
   PubMed Web of Science ®Google Scholar
• Arnold C. Alternative analgesics: New drugs for pain seek to improve on ketamine’s benefits. Nat Med. 2017 Jan 6;23(1):8–10. PMID: 28060800. doi: 10.1038/nm0117-8
   PubMed Web of Science ®Google Scholar
• Wallace MS, Ridgeway BM, Leung AY, et al. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology. 2000 Jan;92(1):75–83. PMID: 10638902. doi: 10.1097/00000542-200001000-00017
   PubMed Web of Science ®Google Scholar
• O’Connell NE, Wand BM, Gibson W, et al. Local anaesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev. 2016 Jul 28;7(7):CD004598. doi: 10.1002/14651858.CD004598.pub4
   PubMedGoogle Scholar
• Leung SYD, Meng F, Liu J, et al. Sub-anaesthetic dose of propofol attenuates mechanical allodynia in chronic post-ischaemic pain via regulation of PTEN/PI3K/IL-6 signalling. Mol Pain. 2023 Jan;19: 17448069231185232. doi: 10.1177/17448069231185232
   Web of Science ®Google Scholar
• Sigtermans MJ, van Hilten JJ, Bauer MCR, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009 Oct;145(3):304–311. doi: 10.1016/j.pain.2009.06.023
   PubMed Web of Science ®Google Scholar
• Kim M, Cho S, Lee JH. The effects of long-term ketamine treatment on cognitive function in complex regional pain syndrome: a preliminary study. Pain Med. 2016 Aug;17(8):1447–1451. Epub 2016 Feb 27. PMID: 26921891. doi: 10.1093/pm/pnv112
   PubMed Web of Science ®Google Scholar
• Mangnus TJP, Dirckx M, Bharwani KD, et al. Effect of intravenous low-dose S-ketamine on pain in patients with complex regional pain syndrome: a retrospective cohort study. Pain Pract. 2021, Nov;21(8):890–897.
   PubMed Web of Science ®Google Scholar
• Hong SW, Hwang MS, Kim JH, et al. Usefulness of the perfusion index for monitoring the response to intravenous ketamine infusion therapy in patients with complex regional pain syndrome. Pain Pract. 2023, Jun;23(5):535–542.
   PubMed Web of Science ®Google Scholar
• Zhao J, Wang Y, Wang D. The effect of ketamine infusion in the treatment of complex regional pain syndrome: a systemic review and meta-analysis. Curr Pain Headache Rep. 2018 Feb 5;22(2):12. PMID: 29404715. doi: 10.1007/s11916-018-0664-x
   PubMed Web of Science ®Google Scholar
• Chang MC, Park D. Effectiveness of perampanel in managing chronic pain caused by the complex regional pain syndrome: a case report. Medicine (Baltimore). 2021 Dec 3;100(48):e27791. PMID: 35049177; PMCID: PMC9191566. doi: 10.1097/MD.0000000000027791
   PubMed Web of Science ®Google Scholar
• Muizelaar JP, Kleyer M, Hertogs IA, et al. Complex regional pain syndrome (reflex sympathetic dystrophy and causalgia): management with the calcium channel blocker nifedipine and/or the alpha-sympathetic blocker phenoxybenzamine in 59 patients. Clin Neurol Neurosur. 1997 Feb;99(1):26–30. doi: 10.1016/s0303-8467(96)00594-x
   PubMed Web of Science ®Google Scholar
• Davis KD, Treede RD, Raja SN, et al. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain. 1991 Dec;47(3):309–317. doi: 10.1016/0304-3959(91)90221-I
   PubMed Web of Science ®Google Scholar
• Xu J, Yang J, Lin P, et al. Intravenous therapies for complex regional pain syndrome: a systematic review. Anesth Analg. 2016, Mar;122(3):843–856.
   PubMed Web of Science ®Google Scholar
• Goebel A, Netal S, Schedel R, et al. Human pooled immunoglobulin in the treatment of chronic pain syndromes. Pain Med. 2002 Jun;3(2):119–127. doi: 10.1046/j.1526-4637.2002.02018.x
   PubMed Web of Science ®Google Scholar
• Goebel A, Baranowski A, Maurer K, et al. Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial. Ann Intern Med. 2010 Feb 2;152(3):152–158. doi: 10.7326/0003-4819-152-3-201002020-00006
   PubMed Web of Science ®Google Scholar
• Goebel A, Bisla J, Carganillo R, et al. Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized Trial. Ann Intern Med.2017 Oct 3;167(7):476–483. doi: 10.7326/M17-0509
   PubMed Web of Science ®Google Scholar
• Perez RS, Zollinger PE, Dijkstra PU, et al. CRPS I task force. Evidence based guidelines for complex regional pain syndrome type 1. BMC neurol. 2010 Mar 31;10:20. doi: 10.1186/1471-2377-10-20
   PubMed Web of Science ®Google Scholar
• The treatment of distal radius fractures guideline and evidence report adopted by the American Academy of orthopaedic surgeons board of directors. 2009 Dec 5. [cited 2019 Feb 6]. Available from:https://www.aaos.org/uploadedFiles/PreProduction/Quality/Clinical_Quality_and_Value/Upper_Extremities/distal-radius-fractures-clinical-practice-guideline.pdf
   Google Scholar
• Jacques H, Jérôme V, Antoine C, et al. Prospective randomized study of the vitamin C effect on pain and complex pain regional syndrome after total knee arthroplasty. Int Orthop. 2021 May;45(5):1155–1162. Epub 2021 Jan 12. Erratum in: Int Orthop. 2021 Feb 22;: PMID: 33438072. doi: 10.1007/s00264-020-04936-9
   PubMed Web of Science ®Google Scholar
• Seth I, Bulloch G, Seth N, et al. Effect of perioperative vitamin C on the incidence of complex regional pain syndrome: a systematic review and meta-analysis. J Foot Ankle Surg. 2022, Jul;61(4):748–754.
   PubMed Web of Science ®Google Scholar
• Meena S, Sharma P, Gangary SK, et al. Role of vitamin C in prevention of complex regional pain syndrome after distal radius fractures: a meta-analysis. Eur J Orthop Surg Traumatol. 2015, May;25(4):637–641. doi: 10.1007/s00590-014-1573-2
   PubMedGoogle Scholar
• Evaniew N, McCarthy C, Kleinlugtenbelt YV, et al. Vitamin C to prevent complex regional pain syndrome in patients with distal radius fractures: a meta-analysis of randomized controlled trials. J Orthop Trauma. 2015 Aug;29(8):e235–e241. doi: 10.1097/BOT.0000000000000305
   PubMed Web of Science ®Google Scholar
• Finch PM, Knudsen L, Drummond PD. Reduction of allodynia in patients with complex regional pain syndrome: a double-blind placebo-controlled trial of topical ketamine. Pain. 2009 Nov;146(1–2):18–25. Epub 2009 Aug 22. PMID: 19703730. doi: 10.1016/j.pain.2009.05.017
   PubMed Web of Science ®Google Scholar
• Russo MA, Santarelli DM. A novel compound analgesic cream (ketamine, pentoxifylline, clonidine, DMSO) for complex regional pain syndrome patients. Pain Pract. 2016 Jan;16(1):E14–E20. doi: 10.1111/papr.12404
   PubMed Web of Science ®Google Scholar
• Robbins WR, Staats PS, Levine J, et al. Treatment of intractable pain with topical large-dose capsaicin: preliminary report. Anesth Analg. 1998, Mar;86(3):579–83.
   PubMed Web of Science ®Google Scholar
• Zuurmond WW, Langendijk PN, Bezemer PD, et al. Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty cream. Acta Anaesthesiol Scand. 1996 Mar;40(3):364–367. doi: 10.1111/j.1399-6576.1996.tb04446.x
   PubMed Web of Science ®Google Scholar
• Perez MRSG, Zuurmond AWW, Bezemer DP, et al. The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study. Pain. 2003 Apr;102(3):297–307. doi: 10.1016/S0304-3959(02)00414-1
   PubMed Web of Science ®Google Scholar
• Drummond ES, Maker G, Birklein F, et al. Topical prazosin attenuates sensitivity to tactile stimuli in patients with complex regional pain syndrome. Eur J Pain. 2016 Jul;20(6):926–935. doi: 10.1002/ejp.817
   PubMed Web of Science ®Google Scholar
• Mangnus TJP, Bharwani KD, Dirckx M, et al. From a symptom-based to a mechanism-based pharmacotherapeutic treatment in complex regional pain syndrome. Drugs. 2022, Apr;82(5):511–531. doi: 10.1007/s40265-022-01685-4
   PubMed Web of Science ®Google Scholar
• Matak I, Tékus V, Bölcskei K, et al. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: evidence from knockout mice. Neuroscience. 2017 Sep 1;358:137–145. doi: 10.1016/j.neuroscience.2017.06.040
   PubMed Web of Science ®Google Scholar
• Rand MJ, Whaler BC. Impairment of sympathetic transmission by botulinum toxin. Nature. 1965 May 8;206(984):588–591. doi: 10.1038/206588a0
   PubMedGoogle Scholar
• Attal N, de Andrade DC, Adam F, et al. Safety and efficacy of repeated injections of botulinum toxin a in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2016, May;15(6):555–565. doi: 10.1016/S1474-4422(16)00017-X
   PubMed Web of Science ®Google Scholar
• Safarpour D, Salardini A, Richardson D, et al. Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study. Pain Med. 2010 Sep;11(9):1411–1414. doi: 10.1111/j.1526-4637.2010.00897.x
   PubMed Web of Science ®Google Scholar
• Kharkar S, Ambady P, Yedatore V, et al. Intramuscular botulinum toxin A (BtxA) in complex regional pain syndrome. Pain Physician. 2011 May;14(3):311–316. doi: 10.36076/ppj.2011/14/311
   PubMed Web of Science ®Google Scholar
• Bellon G, Venturin A, Masiero S, et al. Intra-articular botulinum toxin injection in complex regional pain syndrome: case report and review of the literature. Toxicon. 2019 Mar 1;159:41–44.doi: 10.1016/j.toxicon.2019.01.002
   PubMed Web of Science ®Google Scholar
• Choi E, Cho CW, Kim HY, et al. Lumbar Sympathetic Block with Botulinum Toxin Type B for Complex Regional Pain Syndrome: A Case Study. Pain Physician. 2015 Sep;18(5):E911–E916. doi: 10.36076/ppj.2015/18/E911
   PubMed Web of Science ®Google Scholar
• Yoo Y, Lee CS, Kim J, et al. Botulinum Toxin Type A for Lumbar Sympathetic Ganglion Block in Complex Regional Pain Syndrome: A Randomized Trial. Anesthesiology. 2022 Feb 1;136(2):314–325. doi: 10.1097/ALN.0000000000004084
   PubMed Web of Science ®Google Scholar
• Cornish J, Bava U, Callon KE, et al. Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells. Bone. 2011, Oct;49(4):710–6. doi: 10.1016/j.bone.2011.07.020
   PubMed Web of Science ®Google Scholar
• Sevcik MA, Luger NM, Mach DB, et al. Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis. Pain. 2004 Sep;111(1–2):169–180. doi: 10.1016/j.pain.2004.06.015
   PubMed Web of Science ®Google Scholar
• Iolascon G, Moretti A. The rationale for using neridronate in musculoskeletal disorders: from metabolic bone diseases to musculoskeletal pain. Int J Mol Sci. 2022 Jun 22;23(13):6921. doi: 10.3390/ijms23136921
   PubMed Web of Science ®Google Scholar